Progenics Pharmaceuticals Inc. Press Releases

Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
05/17/2013 5:14PM - GlobeNewswire

Faruqi & Faruqi, LLP Launches An Investigation Against Progenics Pharmaceuticals, Inc. (PGNX) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
05/10/2013 6:45PM - Business Wire

Progenics Pharmaceuticals Announces First Quarter 2013 Financial Results
05/10/2013 7:30AM - GlobeNewswire

Progenics Pharmaceuticals to Host Conference Call to Review First Quarter 2013 Financial Results on May 10
05/06/2013 5:12PM - GlobeNewswire

Progenics Pharmaceuticals to Present at Needham Healthcare Conference
04/24/2013 5:17PM - GlobeNewswire

Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation, Progenics Pharmaceuticals
03/19/2013 8:00AM - PR Newswire

Squawk Box Stocks Reports on: Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), Groupon, Inc. (NASDAQ: GRPN), Glu Mobile, Inc. (NASDAQ: GLUU), 3D Systems Corp. (NYSE: DDD)
03/18/2013 8:00AM - Market Wire

Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2012 Financial Results
03/15/2013 7:42AM - GlobeNewswire

Progenics Pharmaceuticals to Host Conference Call to Review Fourth Quarter Financial Results on March 15
03/08/2013 3:15PM - GlobeNewswire

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
03/08/2013 8:20AM - Market Wire

Progenics Pharmaceuticals' Novel Small Molecule Drugs Targeting PSMA Successfully Visualize Prostate Cancer
03/05/2013 9:00AM - GlobeNewswire